LENZ Therapeutics (LENZ) Non-cash Items (2020 - 2023)

LENZ Therapeutics (LENZ) has 4 years of Non-cash Items data on file, last reported at $847000.0 in Q4 2023.

• Quarterly Non-cash Items rose 6.68% year-over-year to $847000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $847000.0 (up 6.68% YoY) and the FY2023 annual result came in at $847000.0, down 63.65% from the prior year.
• Non-cash Items declined to $847000.0 in Q4 2023 per LENZ's latest filing, from $4.2 million in the prior quarter.
• Across five years, Non-cash Items topped out at $113.0 million in Q2 2021 and bottomed at $769000.0 in Q3 2022.
• The 4-year median for Non-cash Items is $1.4 million (2020), against an average of $15.6 million.
• The widest annual swing landed in 2021, when Non-cash Items soared 1255.53%; it then sank 98.69% in 2022.
• Tracing LENZ's Non-cash Items over 4 years: stood at $1.4 million in 2020, then soared by 1255.53% to $18.5 million in 2021, then plunged by 95.71% to $794000.0 in 2022, then gained by 6.68% to $847000.0 in 2023.
• Per Business Quant, the three latest LENZ Non-cash Items figures stand at $847000.0 (Q4 2023), $4.2 million (Q3 2023), and $3.6 million (Q2 2023).

Peer Comparison